Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Vivity EDOF IOL Implantation in Patients With Well Controlled OAG or OHT

NCT05075226 is registered in ClinicalTrials.gov with Maisonneuve-Rosemont Hospital as lead sponsor.

NCT NCT05075226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05075226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Vivity EDOF IOL Implantation in Patients With Well Controlled OAG or OHT
Lead sponsor
Maisonneuve-Rosemont Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 29, 2021
Completion date
August 31, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with primary open angle glaucoma (poag) or ocular hypertension (oht)